Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
HealthEquity
(NASDAQ:HQY)
Intraday
$79.87
0
[0.00%]
15 minutes delayed
Get Report
Watch
Perks
Buy
Compare Brokers
$79.87
0
[0.00%]
Last update: 4:20PM
Get Real Time Here
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for HealthEquity Stock (NASDAQ:HQY)
HealthEquity Stock (NASDAQ: HQY)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, April 04, 2024
JMP Securities Initiates Coverage On HealthEquity with Market Outperform Rating, Announces Price Target of $101
Benzinga Newsdesk
-
Apr 4, 2024, 4:56AM
Tuesday, April 02, 2024
JP Morgan Maintains Overweight on HealthEquity, Raises Price Target to $108
Benzinga Newsdesk
-
Apr 2, 2024, 10:32AM
Friday, March 22, 2024
Keybanc Maintains Overweight on HealthEquity, Raises Price Target to $95
Benzinga Newsdesk
-
Mar 22, 2024, 1:46PM
Barrington Research Maintains Outperform on HealthEquity, Announces $100 Price Target
Benzinga Newsdesk
-
Mar 22, 2024, 11:10AM
Wednesday, March 20, 2024
RBC Capital Maintains Outperform on HealthEquity, Raises Price Target to $92
Benzinga Newsdesk
-
Mar 20, 2024, 11:05AM
B of A Securities Maintains Buy on HealthEquity, Raises Price Target to $97
Benzinga Newsdesk
-
Mar 20, 2024, 7:12AM
Micron, Signet Jewelers And 3 Stocks To Watch Heading Into Wednesday
Avi Kapoor
-
Mar 20, 2024, 2:44AM
Tuesday, March 19, 2024
Recap: HealthEquity Q4 Earnings
Benzinga Insights
-
Mar 19, 2024, 4:10PM
HealthEquity shares are trading lower despite better-than-expected Q4 results.
Benzinga Newsdesk
-
Mar 19, 2024, 4:05PM
HealthEquity Sees FY24 Revenues $1.14B-$1.16B vs $995.9M Est.; Sees Adj. EPS $2.79-$2.96 vs $2.83 Est.
Benzinga Newsdesk
-
Mar 19, 2024, 4:03PM
HealthEquity Q4 2024 Adj EPS $0.63 Beats $0.56 Estimate, Sales $262.400M Beat $258.466M Estimate
Benzinga Newsdesk
-
Mar 19, 2024, 4:01PM
Earnings Scheduled For March 19, 2024
Benzinga Insights
-
Mar 19, 2024, 6:06AM
Monday, March 18, 2024
Earnings Outlook For HealthEquity
Benzinga Insights
-
Mar 18, 2024, 10:00AM
Friday, February 23, 2024
RBC Capital Maintains Outperform on HealthEquity, Raises Price Target to $90
Benzinga Newsdesk
-
Feb 23, 2024, 11:12AM
Wednesday, February 21, 2024
HealthEquity Reports Year-End Sales Metrics; Sees FY24 EPS $2.20-$2.24 Vs $2.14 Est.; Revenue $995M-$1B Vs $992.74M Est.; FY25 Revenue $1.14B-$1.16B Vs $1.15B Est.;
Benzinga Newsdesk
-
Feb 21, 2024, 4:24PM
Thursday, January 25, 2024
Affordable Care Act Enrollment Highest Since Inception: Obamacare Enrollment Witnesses 31% Jump in 2024
Vandana Singh
-
Jan 25, 2024, 9:44AM
Thursday, January 18, 2024
Medicare Patients Alert! Biden Administration Finalizes Rule to Streamline Health Insurance Prior Authorization
Vandana Singh
-
Jan 18, 2024, 10:23AM
Monday, January 08, 2024
HealthEquity Estimates Health Savings Accounts ~8.7M By Jan. 31, Up From 8M YoY; Estimated HSA Assets To Be ~$24.5B, Up From $22.1B At The End Of Fiscal Year 2023, With ~$15B Of HSA Cash
Benzinga Newsdesk
-
Jan 8, 2024, 9:08AM
Thursday, December 14, 2023
Insider Transaction: Elimelech Rosner Sells $141K Worth Of HealthEquity Shares
Benzinga Insights
-
Dec 14, 2023, 10:03AM
Wednesday, December 13, 2023
Raymond James Maintains Outperform on HealthEquity, Raises Price Target to $95
Benzinga Newsdesk
-
Dec 13, 2023, 1:49PM
Wednesday, December 06, 2023
What 4 Analyst Ratings Have To Say About HealthEquity
Benzinga Insights
-
Dec 6, 2023, 1:00PM
Wells Fargo Maintains Overweight on HealthEquity, Raises Price Target to $93
Benzinga Newsdesk
-
Dec 6, 2023, 12:27PM
Tuesday, December 05, 2023
HealthEquity: Q3 Earnings Insights
Benzinga Insights
-
Dec 5, 2023, 4:05PM
HealthEquity Sees FY24 Adj. EPS $2.08-$2.16 vs $2.02 Est., Revenue $985M-$995M vs $989M Est.
Benzinga Newsdesk
-
Dec 5, 2023, 4:03PM
HealthEquity Q3 Adj $0.60 Beats $0.50 Estimate
Benzinga Newsdesk
-
Dec 5, 2023, 4:02PM
Earnings Scheduled For December 5, 2023
Benzinga Insights
-
Dec 5, 2023, 6:08AM
Monday, December 04, 2023
Barrington Research Reiterates Outperform on HealthEquity, Maintains $85 Price Target
Benzinga Newsdesk
-
Dec 4, 2023, 12:38PM
Earnings Outlook For HealthEquity
Benzinga Insights
-
Dec 4, 2023, 9:00AM
Friday, December 01, 2023
JP Morgan Maintains Overweight on HealthEquity, Lowers Price Target to $73
Benzinga Newsdesk
-
Dec 1, 2023, 2:37PM
Thursday, September 21, 2023
Benzinga's Top Ratings Upgrades, Downgrades For September 21, 2023
Benzinga Insights
-
Sep 21, 2023, 11:00AM
4 Analysts Have This to Say About HealthEquity
Benzinga Insights
-
Sep 21, 2023, 8:01AM
CrowdStrike Holdings To Rally Over 31%? Here Are 10 Other Analyst Forecasts For Thursday
Lisa Levin
-
Sep 21, 2023, 7:48AM
Baird Upgrades HealthEquity to Outperform, Raises Price Target to $87
Benzinga Newsdesk
-
Sep 21, 2023, 5:43AM
Tuesday, September 19, 2023
Conduent's BenefitWallet HSA Portfolio Moving To HealthEquity; The Agreement Contemplates A Purchase Price Of ~$425M For The Transition Of All BenefitWallet HSA Accounts
Benzinga Newsdesk
-
Sep 19, 2023, 9:17AM
Thursday, September 07, 2023
Deutsche Bank Maintains Buy on HealthEquity, Raises Price Target to $72
Benzinga Newsdesk
-
Sep 7, 2023, 11:22AM
Wednesday, September 06, 2023
HealthEquity shares are trading higher after the company reported better-than-expected Q2 results and issued strong guidance.
Benzinga Newsdesk
-
Sep 6, 2023, 1:16PM
Barrington Research Reiterates Outperform on HealthEquity, Raises Price Target to $85
Benzinga Newsdesk
-
Sep 6, 2023, 11:27AM
RBC Capital Maintains Outperform on HealthEquity, Raises Price Target to $77
Benzinga Newsdesk
-
Sep 6, 2023, 10:05AM
Tuesday, September 05, 2023
HealthEquity Sees FY24 Adj. EPS $1.97-$2.06 vs $1.92 Est., Revenue $980M-$990M vs $981.07M Est.
Benzinga Newsdesk
-
Sep 5, 2023, 4:01PM
HealthEquity Q2 EPS $0.53 Beats $0.47 Estimate, Sales $243.50M Beat $238.89M Estimate
Benzinga Newsdesk
-
Sep 5, 2023, 4:00PM
Earnings Scheduled For September 5, 2023
Benzinga Insights
-
Sep 5, 2023, 6:37AM
Monday, September 04, 2023
HealthEquity Earnings Preview
Benzinga Insights
-
Sep 4, 2023, 10:01AM
Wednesday, June 14, 2023
HealthEquity Announces James Lucania As Executive Vice President And CFO; Succeeds Tyson Murdock Effective September After Filing Q2 Report
Benzinga Newsdesk
-
Jun 14, 2023, 9:03AM
Monday, June 12, 2023
HealthEquity's High-Margin HSA Assets: Analyst's Perspective On Their Impact On Revenue
Nabaparna Bhattacharya
-
Jun 12, 2023, 2:39PM
Thursday, June 08, 2023
American Express, EQT, HealthEquity And A Major Wireless Carrier With A 7% Dividend Yield: CNBC's 'Final Trades'
Lisa Levin
-
Jun 8, 2023, 8:18AM
Wednesday, June 07, 2023
CNBC Halftime Report Final Trades: HealthEquity, AT&T, American Express, EQT Corporation
Happy Mohamed
-
Jun 7, 2023, 12:59PM
Deutsche Bank Maintains Buy on HealthEquity, Raises Price Target to $71
Benzinga Newsdesk
-
Jun 7, 2023, 11:01AM
Tuesday, June 06, 2023
Why HealthEquity Stock Is Up Today
Ryan Gustafson
-
Jun 6, 2023, 3:27PM
HealthEquity To Capture More Market Share, Says Analyst In Overweight Rating Rationale
Nabaparna Bhattacharya
-
Jun 6, 2023, 2:59PM
HealthEquity shares are trading higher after the company reported better-than-expected Q1 results and issued guidance above estimates.
Benzinga Newsdesk
-
Jun 6, 2023, 2:47PM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch